{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:50:01Z","timestamp":1790232601245,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006390","name":"University of Lausanne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006390","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To evaluate the performance of the Duke clinical criteria of the European Society of Cardiology (ESC; 2015 and 2023 versions) and the 2023 International Society for Cardiovascular Infectious Diseases (ISCVID) in diagnosing infective endocarditis (IE) among patients with bacteraemia\/candidaemia by pathogens introduced for the first time as typical microorganisms by ISCVID.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>\n                      This study included adult patients with bacteraemia\/candidaemia by such pathogens (coagulase negative staphylococci,\n                      <jats:italic>Abiotrophia<\/jats:italic>\n                      spp.,\n                      <jats:italic>Gemella<\/jats:italic>\n                      spp., and\n                      <jats:italic>Granulicatella<\/jats:italic>\n                      spp.,\n                      <jats:italic>Cutibacterium. acnes<\/jats:italic>\n                      ,\n                      <jats:italic>Corynebacterium striatum<\/jats:italic>\n                      ,\n                      <jats:italic>C. jeikeium<\/jats:italic>\n                      ,\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      ,\n                      <jats:italic>Serratia marcescens<\/jats:italic>\n                      , non-tuberculous mycobacteria, and\n                      <jats:italic>Candida<\/jats:italic>\n                      spp.) hospitalized at Lausanne University Hospital. Episodes were classified as IE by two expert clinicians.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 463 episodes with bacteraemia\/candidaemia by such pathogens, IE was diagnosed in 63 episodes (14%). IE prevalence was 17% among episodes with bacteraemia by\n                      <jats:italic>Staphylococcus lugdunensis<\/jats:italic>\n                      or\n                      <jats:italic>Abiotrophia spp<\/jats:italic>\n                      . No case of IE was identified among\n                      <jats:italic>Granulicatella<\/jats:italic>\n                      spp. and\n                      <jats:italic>Gemella<\/jats:italic>\n                      spp. bacteraemias. Among 113 episodes with intracardiac prosthetic material, IE prevalence was 51% in episodes with bacteraemia by\n                      <jats:italic>S. epidermidis<\/jats:italic>\n                      . Sensitivity for the 2015 Duke-ESC, 2023 Duke-ISCVID, and the 2023 Duke-ESC clinical criteria was calculated at 5%, 57%, and 8%, respectively. More episodes were classified as possible IE by the 2023 Duke-ISCVID (30%) compared to 2015 Duke-ESC (13%) and 2023 Duke-ESC (16%) clinical criteria.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The 2023 ISCVID version demonstrated superior sensitivity compared to both 2015 and 2023 Duke-ESC in diagnosing IE caused by new typical microorganisms, compared to the other criteria, albeit an increase in cases being classified as possible IE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s15010-024-02460-1","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T07:55:42Z","timestamp":1738223742000},"page":"1393-1401","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with positive blood cultures for new typical microorganisms"],"prefix":"10.1007","volume":"53","author":[{"given":"Nicolas","family":"Fourr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virgile","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Senn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Monney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tzimas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Tagini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Guery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0565-5105","authenticated-orcid":false,"given":"Matthaios","family":"Papadimitriou-Olivgeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"44","key":"2460_CR1","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the management of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-thoracic surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075\u2013128. https:\/\/doi.org\/10.1093\/eurheartj\/ehv319.","journal-title":"Eur Heart J"},{"issue":"3","key":"2460_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","volume":"96","author":"DT Durack","year":"1994","unstructured":"Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service Am J Med. 1994;96(3):200\u20139. https:\/\/doi.org\/10.1016\/0002-9343(94)90143-0.","journal-title":"Duke Endocarditis Service Am J Med"},{"issue":"4","key":"2460_CR3","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr., Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2000;30(4):633\u20138. https:\/\/doi.org\/10.1086\/313753.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"2460_CR4","doi-asserted-by":"publisher","unstructured":"Fowler VG, Durack DT, Selton-Suty C, Athan E, Bayer AS, Chamis AL, et al. The 2023 Duke-ISCVID Criteria for Infective endocarditis: updating the modified Duke Criteria. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2023. https:\/\/doi.org\/10.1093\/cid\/ciad271.","DOI":"10.1093\/cid\/ciad271"},{"issue":"10","key":"2460_CR5","doi-asserted-by":"publisher","first-page":"ofz437","DOI":"10.1093\/ofid\/ofz437","volume":"6","author":"A Berge","year":"2019","unstructured":"Berge A, Kronberg K, Sunnerhagen T, Nilson BHK, Giske CG, Rasmussen M. Risk for Endocarditis in Bacteremia with Streptococcus-Like Bacteria: a Retrospective Population-based Cohort Study. Open Forum Infect Dis. 2019;6(10):ofz437. https:\/\/doi.org\/10.1093\/ofid\/ofz437.","journal-title":"Open Forum Infect Dis"},{"key":"2460_CR6","doi-asserted-by":"publisher","unstructured":"Aldman MH, Rasmussen M, Olaison L, Pahlman LI. Endocarditis due to Staphylococcus lugdunensis-a retrospective national registry-based study. European journal of clinical microbiology & infectious diseases: official publication of the European Society of Clinical Microbiology. 2021;40(5):1103\u20136. https:\/\/doi.org\/10.1007\/s10096-020-04134-w","DOI":"10.1007\/s10096-020-04134-w"},{"issue":"2","key":"2460_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jinf.2016.10.003","volume":"74","author":"LR Non","year":"2017","unstructured":"Non LR, Santos CA. The occurrence of infective endocarditis with Staphylococcus lugdunensis bacteremia: a retrospective cohort study and systematic review. J Infect. 2017;74(2):179\u201386. https:\/\/doi.org\/10.1016\/j.jinf.2016.10.003.","journal-title":"J Infect"},{"issue":"4","key":"2460_CR8","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1099\/00207713-45-4-798","volume":"45","author":"Y Kawamura","year":"1995","unstructured":"Kawamura Y, Hou XG, Sultana F, Liu S, Yamamoto H, Ezaki T. Transfer of Streptococcus adjacens and Streptococcus defectivus to Abiotrophia gen. nov. as Abiotrophia adiacens comb. nov. and Abiotrophia defectiva comb. nov., respectively. Int J Syst Bacteriol. 1995;45(4):798\u2013803. https:\/\/doi.org\/10.1099\/00207713-45-4-798.","journal-title":"Int J Syst Bacteriol"},{"issue":"10","key":"2460_CR9","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S1473-3099(17)30324-9","volume":"17","author":"J van Ingen","year":"2017","unstructured":"van Ingen J, Kohl TA, Kranzer K, Hasse B, Keller PM, Katarzyna Szafranska A, et al. Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study. Lancet Infect Dis. 2017;17(10):1033\u201341. https:\/\/doi.org\/10.1016\/S1473-3099(17)30324-9.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"2460_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1093\/europace\/euaa076","volume":"22","author":"R Mateos Gaitan","year":"2020","unstructured":"Mateos Gaitan R, Boix-Palop L, Munoz Garcia P, Mestres CA, Marin Arriaza M, Pedraz Prieto A, et al. Infective endocarditis in patients with cardiac implantable electronic devices: a nationwide study. Europace. 2020;22(7):1062\u201370. https:\/\/doi.org\/10.1093\/europace\/euaa076.","journal-title":"Europace"},{"issue":"12","key":"2460_CR11","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jama.297.12.1354","volume":"297","author":"A Wang","year":"2007","unstructured":"Wang A, Athan E, Pappas PA, Fowler VG Jr., Olaison L, Pare C, et al. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007;297(12):1354\u201361. https:\/\/doi.org\/10.1001\/jama.297.12.1354.","journal-title":"JAMA"},{"issue":"3","key":"2460_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/joim.13491","volume":"292","author":"B Berisha","year":"2022","unstructured":"Berisha B, Ragnarsson S, Olaison L, Rasmussen M. Microbiological etiology in prosthetic valve endocarditis: a nationwide registry study. J Intern Med. 2022;292(3):428\u201337. https:\/\/doi.org\/10.1111\/joim.13491.","journal-title":"J Intern Med"},{"key":"2460_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad193","author":"V Delgado","year":"2023","unstructured":"Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al. 2023 ESC guidelines for the management of endocarditis. Eur Heart J. 2023. https:\/\/doi.org\/10.1093\/eurheartj\/ehad193.","journal-title":"Eur Heart J"},{"key":"2460_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae003","author":"M Papadimitriou-Olivgeris","year":"2024","unstructured":"Papadimitriou-Olivgeris M, Monney P, Frank M, Tzimas G, Tozzi P, Kirsch M, et al. Evaluation of the 2023 Duke-ISCVID and 2023 Duke-ESC clinical criteria for the diagnosis of infective endocarditis in a multicenter cohort of patients with Staphylococcus aureus bacteremia. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae003.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"2460_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae039","author":"M Papadimitriou-Olivgeris","year":"2024","unstructured":"Papadimitriou-Olivgeris M, Monney P, Frank M, Tzimas G, Tozzi P, Kirsch M, et al. Evaluation of the 2023 Duke-ISCVID criteria in a multicenter cohort of patients with suspected infective endocarditis. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae039.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"2460_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae040","author":"H Lindberg","year":"2024","unstructured":"Lindberg H, Berge A, Jovanovic-Stjernqvist M, Hagstrand Aldman M, Krus D, Oberg J, et al. Performance of the 2023 Duke-ISCVID diagnostic criteria for infective endocarditis in relation to the modified Duke criteria and to clinical management- reanalysis of retrospective bacteremia cohorts. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae040.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"2460_CR17","doi-asserted-by":"publisher","unstructured":"van der Vaart TW, Bossuyt PMM, Durack DT, Baddour LM, Bayer AS, Durante-Mangoni E, et al. External validation of the 2023 Duke - International Society for Cardiovascular Infectious diseases Diagnostic Criteria for Infective Endocarditis. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae033.","DOI":"10.1093\/cid\/ciae033"},{"key":"2460_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae035","author":"F Goehringer","year":"2024","unstructured":"Goehringer F, Lalloue B, Selton-Suty C, Alla F, Botelho-Nevers E, Chirouze C, et al. Compared performance of the 2023 Duke-International Society for Cardiovascular Infectious Diseases, the 2000 modified Duke, and the 2015 ESC Criteria for the diagnosis of infective endocarditis in a French multicenter prospective cohort. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae035.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"2460_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae370","author":"M Papadimitriou-Olivgeris","year":"2024","unstructured":"Papadimitriou-Olivgeris M, Monney P, Frank M, Tzimas G, Fourre N, Zimmermann V, et al. Comparison of the 2015 and 2023 European Society of Cardiology versions of the Duke criteria among patients with suspected infective endocarditis. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae370.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"2460_CR20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae315","author":"N Fourre","year":"2024","unstructured":"Fourre N, Zimmermann V, Senn L, Monney P, Tzimas G, Caruana G, et al. Evaluation of the HANDOC score and the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with streptococcal bacteremia. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae315.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"key":"2460_CR21","doi-asserted-by":"publisher","unstructured":"Croxatto A, Prod\u2019hom G, Durussel C, Greub G. Preparation of a blood culture pellet for rapid bacterial identification and antibiotic susceptibility testing. J Vis Exp. 2014(92):e51985. https:\/\/doi.org\/10.3791\/51985","DOI":"10.3791\/51985"},{"key":"2460_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.mimet.2018.07.017","volume":"152","author":"S Tsuchida","year":"2018","unstructured":"Tsuchida S, Murata S, Miyabe A, Satoh M, Takiwaki M, Ashizawa K, et al. Application of the biocopolymer preparation system, rapid BACpro(R) II kit, for mass-spectrometry-based bacterial identification from positive blood culture bottles by the MALDI biotyper system. J Microbiol Methods. 2018;152:86\u201391. https:\/\/doi.org\/10.1016\/j.mimet.2018.07.017.","journal-title":"J Microbiol Methods"},{"issue":"10","key":"2460_CR23","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1007\/s10096-019-03621-z","volume":"38","author":"A Simon","year":"2019","unstructured":"Simon A, Onya O, Mazza-Stalder J, Nicod L, Gilbert G, Katia J. Added diagnostic value of 16S rRNA gene pan-mycobacterial PCR for nontuberculous mycobacterial infections: a 10-year retrospective study. Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol. 2019;38(10):1873\u201381. https:\/\/doi.org\/10.1007\/s10096-019-03621-z.","journal-title":"Eur J Clin Microbiol Infect Diseases: Official Publication Eur Soc Clin Microbiol"},{"key":"2460_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae034","author":"H Moisset","year":"2024","unstructured":"Moisset H, Rio J, Benhard J, Arnoult F, Deconinck L, Grall N, et al. Evaluation of the specificity of the 2023 Duke-International Society of Cardiovascular Infectious diseases classification for infective endocarditis. Clin Infect Diseases: Official Publication Infect Dis Soc Am. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae034.","journal-title":"Clin Infect Diseases: Official Publication Infect Dis Soc Am"},{"issue":"5","key":"2460_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","volume":"169","author":"DR Murdoch","year":"2009","unstructured":"Murdoch DR, Corey GR, Hoen B, Miro JM, Fowler VG Jr., Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169(5):463\u201373. https:\/\/doi.org\/10.1001\/archinternmed.2008.603.","journal-title":"Arch Intern Med"},{"key":"2460_CR26","doi-asserted-by":"publisher","unstructured":"Haddad SF, Lahr BD, Patarroyo SS, Chesdachai S, Kies KD, O\u2019Horo JC, et al. Bloodstream infection due to coagulase-negative staphylococci: impact of species on prevalence of infective endocarditis. Antibiotics. 2023;12(9). https:\/\/doi.org\/10.3390\/antibiotics12091453.","DOI":"10.3390\/antibiotics12091453"},{"issue":"3","key":"2460_CR27","doi-asserted-by":"publisher","first-page":"ofx132","DOI":"10.1093\/ofid\/ofx132","volume":"4","author":"SA Maskarinec","year":"2017","unstructured":"Maskarinec SA, Thaden JT, Cyr DD, Ruffin F, Souli M, Fowler VG. The risk of Cardiac device-related infection in bacteremic patients is Species Specific: results of a 12-Year prospective cohort. Open Forum Infect Dis. 2017;4(3):ofx132. https:\/\/doi.org\/10.1093\/ofid\/ofx132.","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"2460_CR28","doi-asserted-by":"publisher","first-page":"106734","DOI":"10.1016\/j.ijantimicag.2023.106734","volume":"61","author":"R Pascale","year":"2023","unstructured":"Pascale R, Toschi A, Aslan AT, Massaro G, Maccaro A, Fabbricatore D, et al. Risk factors for Gram-negative bacterial infection of cardiovascular implantable electronic devices: multicentre observational study (CarDINe Study). Int J Antimicrob Agents. 2023;61(3):106734. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106734.","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"2460_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/23744235.2023.2226212","volume":"55","author":"M Sebillotte","year":"2023","unstructured":"Sebillotte M, Boutoille D, Declerck C, Talarmin JP, Lemaignen A, Piau C, et al. Non-HACEK gram-negative bacilli endocarditis: a multicentre retrospective case-control study. Infect Dis. 2023;55(9):599\u2013606. https:\/\/doi.org\/10.1080\/23744235.2023.2226212.","journal-title":"Infect Dis"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02460-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02460-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:04:37Z","timestamp":1754352277000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02460-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2460"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02460-1","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study adhered to the Declaration of Helsinki and was approved by the ethics committee of the Canton of Vaud (CER-VD 2021\u201302516, CER-VD 2017\u201302137).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Due to the retrospective nature of the study, the ethic committee waived the need of informed consent to participate. However, patients were excluded if they had previously refused to permit the use of their data for research purposes.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}